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7 Abstract The objective of this research was to investi-
8 gate the feasibility of the interaction between
9 indomethacin-nicotinamide cocrystals with β-cyclodextrin
10 and hydroxypropyl-β-cyclodextrin in the solid-state. The
11 study has emphasized on the possibility of inclusion
12 complex formation and its effect on the dissolution per-
13 formance of the cocrystals. The solid systems in the molar
14 ratio of 1:1 of the host and guest molecules were prepared
15 by co-grinding and co-evaporation methods and compared
16 with their physical mixtures. Furthermore, the molecular
17 behaviors of the cocrystals in all prepared samples were
18 thoroughly characterized by powder X-ray diffraction,
19 differential scanning calorimetry, Fourier-transform infra-
20 red spectroscopy, scanning electron microscopy and
21 in vitro dissolution performance. The results of these
22 studies indicated that complexes prepared by the co-evap-
23 oration method with hydroxypropyl-β-cyclodextrin have
24 shown complete inclusion of the cocrystals into the
25 cyclodextrin cavity and a partial inclusion with β-cy-
26 clodextrin. Moreover, a signiﬁcant (p \ 0.05; ANOVA/
27 Tukey) higher in vitro dissolution was achieved in co-
28 evaporate complex prepared with hydroxypropyl-β-cy-
29 clodextrin compared to that prepared with β-cyclodextrin,
30 indomethacin-nicotinamide cocrystals and indomethacin
31 itself.2
33Keywords Cocrystals · β-Cyclodextrins · HP-β-
34Cyclodextrin · Indomethacin · Inclusion complexation ·
35Nicotinamide
36Introduction
37In the development and manufacture of pharmaceutical
38products, improving the physicochemical properties of
39drugs is often essential but can be challenging. Because
40these improvements can often be achieved by making new
41solid forms of the drug without altering its chemical
42structure. Recent research has focused on identifying
43polymorphs, hydrates, solvates, salts and, more recently,
44cocrystals of drugs [1]. Cocrystals are composed of mul-
45tiple molecular components, including the drug and a
46benign, non-toxic ‘coformer’ molecule. The design, for-
47mation and understanding of the physicochemical
48properties of cocrystals have received considerable atten-
49tion [2–5]. Indeed, pharmaceutical cocrystals are an
50attractive alternative solid form with the potential to ﬁne
51tune the physicochemical properties of drugs [6].
52Inclusion or host–guest complexes are supramolecular
53systems where one chemical compound (the host) has a
54cavity, in which molecules of a second compound (the
55guest) are located [7, 8]. The study of non-covalent forces
56involved in the formation of host–guest complexes is of
57paramount importance for the design of synthetic inclusion
58compounds of active pharmaceutical ingredients (APIs).
59β-Cyclodextrin (β-CD) is a cyclic oligosaccharide con-
60sisting of seven glucose units linked by α (1 → 4) bonds,
61resulting in a hollow truncated cone shape [9]. In water
62they have a hydrophilic outer surface and a hydrophobic
63central cavity able to include a wide variety of lipophilic
64guest molecules, with suitable polarity and dimensions,
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65 without the formation of any covalent bond [10]. Com-
66 plexation with β-CD has found extensive applications in
67 pharmaceutical technology to enhance the aqueous solu-
68 bility, dissolution rate, bioavailability, and stability of
69 poorly water soluble drugs [11, 12]. Unsubstituted β-CD
70 has poor water solubility (16 mg mL−1 at 25 °C), whereas
71 random substitution of the hydroxyl groups with alkyl or
72 hydroxyalkyl groups is able to increase solubility. There-
73 fore, several synthetically modiﬁed β-CDs were used as
74 multifunctional drug carriers in parenteral formulations,
75 such as hydroxypropyl β-cyclodextrin (HP-β-CD) [13].
76 Indomethacin (IND) (1-(p-chlorobenzoyl)-5-methoxy-2-
77 methylindole-3-acetic acid) (Scheme 1a) is a non-steroidal
78 anti-inﬂammatory drug [14]. It is known to form cocrystals
79 with a non-toxic coformer, nicotinamide (NIC)
80 (Scheme 1b) [15, 16].
81 To the best of our knowledge, indomethacin-nicoti-
82 namide cocrystals (INDNIC) complexation with different
83 cylcodextrins has not been studied before. There is only an
84 available report in the literature about formulation devel-
85 opment of carbamazepine-nicotinamide cocrystals
86 complexed with γ-cyclodextrin using supercritical ﬂuid
87 process [17]. In spite of γ-cyclodextrin is a highly water
88 soluble derivative of cyclodextrins but it is not economic
89 for the pharmaceutical industry. Additionally, the super-
90 critical ﬂuid technology is a complex, expensive and time
91 consuming process. So, the objective of the present work
92 was to study the feasibility of interaction of INDNIC with
93 other types of cyclodextrins e.g., β-CD and HP- β-CD in
94 the solid-state. More economic, simple and fast approaches
95 have been applied to achieve inclusion complex formation
96 which are co-grinding and co-evaporation methods. The
97 study was further aimed to characterize the prepared
98 complexes by powder X-ray diffraction (PXRD), differ-
99 ential scanning calorimetry (DSC), Fourier-transform
100 infrared (FTIR) spectroscopy and scanning electron
101 microscopy (SEM). An in vitro dissolution study was also
102 conducted to show the effect of cocrystals inclusion com-
103 plexation on the dissolution proﬁle of IND after its
104complexation with cyclodextrins compared with uncom-
105plexed (free) INDNIC cocrystals and pure IND.
106Experimental
107Materials
108Indomethacin (γ form), nicotinamide, ethyl acetate,
109methanol were purchased from Sigma-Aldrich (Cairo,
110Egypt). β-cyclodextrin and HP-β-cyclodextrin were pur-
111chased from Fluka Chemie (Switzerland). All chemicals
112and solvents were of analytical grade and used as received.
113Preparation of indomethacin cocrystals
114Indomethacin cocrystals were prepared by slurry crystal-
115lization [18]. A total of approximately 3.578 g of IND and
1161.221 g of NIC in a (1:1 molar ratio) was magnetically
117stirred in 10 ml of ethyl acetate for 5 days at room tem-
118perature. Solids were ﬁltered, dried and analyzed by
119PXRD, DSC and FTIR.
120Preparation of the physical mixtures
121Physical mixtures of INDNIC with β-CD and HP-β-CD in
122(1:1 molar ratio) were prepared by simple blending in a
123glass mortar for 5 min and stored under vacuum in desic-
124cator over calcium chloride for ﬁve consecutive days.
125Preparation of the inclusion complexes
126Co-grinding method
127The ground mixtures of INDNIC with each of β-CD and
128HP-β-CD in (1:1 molar ratio) were prepared using the
129vibrational uniball mill (VEB leuchtenbau-KM1, Ger-
130many) for 15 min. The ground mixtures were sieved to
131obtain a particle size range of 125–250 μm, and then stored
132in a desiccator over calcium chloride for ﬁve consecutive
133days.
134Co-evaporation method
135Co-evaporates of INDNIC with each of β-CD and HP-β-
136CD were prepared by solvent evaporation method in the
137same molar ratio (1:1) as previously reported [19]. Brieﬂy,
138IND-NIC was dissolved in a sufﬁcient volume of methanol.
139Both β-CD and HP-β-CD were dissolved at 40 °C in dis-
140tilled water. INDNIC and respective CD solutions were
141mixed together with constant stirring and kept at 40 °C for
142an hour, then gradually cooled to room temperature over a
143period of 6 h. The solutions were evaporated at 40 °C underScheme 1 The chemical structures of a IND and b NIC
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144 vacuum till a constant weight was achieved. The collected
145 powders were sieved to obtain a particle range of 125–
146 250 μm and stored under vacuum in a desiccator over
147 calcium chloride for ﬁve consecutive days.
148 Instrumentation
149 Powder X-ray diffractometry (PXRD)
150 The powder X-ray diffraction patterns of the solid samples
151 were recorded using a Philips 1710 powder diffractometer
152 with Cu Kα radiation (1.54056 A˚). A Cu target tube
153 operated at a voltage of 40 kV and a current of 40 mA and
154 a single crystal graphite monochromator were employed. A
155 scanning speed of 0.6°/min and a wide angel diffraction of
156 4°\ 2θ\ 60° were applied. Standard polycrystalline sili-
157 con powder was used to calibrate the instrument.
158 Differential scanning calorimetry (DSC)
159 DSC thermograms were obtained by using a Shimadzu
160 DSC-50 (Japan). Samples of about 5 mg were placed in
161 aluminum pans of 50 μL capacity & 0.1 mm thickness,
162 press-sealed with aluminum cover of 0.1 mm thickness. An
163 empty pan sealed in the same way was used as a reference.
164 The thermograms were recorded by heating the samples
165 from 30 to 250 °C at a rate of 10 °C min−1, under nitrogen
166 ﬂow of 40 ml min−1. Indium was used as a standard for
167 calibrating the temperature. Reproducibility was checked
168 by running the samples in triplicate, the standard deviations
169 calculated were found negligible.
170 Infrared spectroscopy
171 FT-infrared spectra were collected in triplicate using a
172 Nicolet 6700 FTIR Advanced Gold Spectrometer in the
173 diffuse reﬂectance mode with potassium bromide as a
174 diluent (1:200), using\10 mg of the solid samples. The
175 spectra were recorded in the range of 400–4000 cm−1 at
176 2 cm−1 spectral resolution with the accumulation of 256
177 spectral scans. The instrument was controlled with OMNIC
178 8 software. Triplicate spectra were averaged to obtain one
179 spectrum for each sample. All FTIR spectra were exported
180 to the Galactic* SPC format using GRAMS AI (Version
181 8.0, Thermo Electron Corp. Waltham, MA, USA) with no
182 further processing.
183 Scanning electron microscopy
184 Particles were visualized by scanning electron microscopy
185 (SEM; Jeol 5400 LV, Japan).
186Particles were mounted on aluminum stubs (pin stubs,
18713 mm), layered with a sticky conductive carbon tab and
188coated in gold (10–15 nm) using an EmiTech K 550X Gold
189Sputter Coater, 25 mA for 3 min.
190In-vitro dissolution
191Dissolution experiments were carried out in triplicate with
192USP apparatus ΙI dissolution using paddle at a rotation
193speed of 100 rpm. Powdered samples of each preparation
194equivalent to 25 mg of IND were added to the dissolution
195medium, 500 mL of phosphate buffer, pH 7.4, kept at
19637 ± 0.5 °C. At appropriate time intervals, 5 mL of the
197solution were withdrawn using cotton plug from the dis-
198solution medium and replaced with an equal volume of the
199fresh dissolution medium equilibrated at 37 °C. Then ali-
200quots were injected into the HPLC system. The HPLC
201system, Knauer, D–14163, Germany, consists of HPLC
202pump, UV- detector, and integration interface box. Chro-
203matographic separation was carried out using Kromasil
204C-18 column (250 9 4.60 mm, particle size: 20 μm). The
205detection wavelength, 377 nm, was determined by scan-
206ning the maximum absorbance wavelength of IND in the
207mobile phase (Methanol: distilled water) using an UV–Vis
208spectrophotometer (Jenway, Model 6305, UK).
209Statistical analysis
210All statistical analysis was performed using One-way
211analysis of variance (ANOVA) with the Tukey’s multiple
212comparisons was employed for comparing the preparations
213with each other (Minitab®16 Statistical Software). Statis-
214tically signiﬁcant differences were assumed when p\0.05.
215All values are expressed as their mean ± standard
216deviation.
217Results and discussions
218The solid-phase identity and purity of INDNIC cocrystals
219were veriﬁed using PXRD, DSC and FTIR prior to the
220inclusion complexation. The PXRD pattern and DSC
221melting curve and FTIR spectrum (Figs. 1a, 3a, 5a, b,
222respectively) of the INDNIC agreed well with the previ-
223ously published data [16].
224PXRD study
225The PXRD patterns of INDNIC, β-CD and their physical,
226co-ground and co-evaporate mixtures were presented in
227Fig. 1. Those with HP-β-CD, in turn, were presented in
228Fig. 2. The diffractograms of both INDNIC cocrystals and
229β-CD exhibited series of intense peaks, which are
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230indicative of their crystallinity. Further, the diffractograms
231of their physical mixtures, co-ground mixtures still showed
232the characteristic peaks of both INDNIC and β-CD how-
233ever, some peaks were reduced in their intensities (Fig. 1;
234traces C-E). Co-evaporate of INDNIC with β-CD showed
235further reduction in other crystalline peaks of INDNIC
236especially the most intense diffraction peaks at
237(2θ) = 15.35°, 23.89° and 27.22° (Fig. 1; trace D). How-
238ever, the diffraction peak of INDNIC at (2θ) = 12.94° was
239disappeared with the recording of a new diffraction peak at
240(2θ) = 12.51° for their co-evaporate product. This may
241indicate that some sort of interaction has been occurred in
242case of the co-evaporate system which has led to formation
243of compound with lower crystallinity as compared with
244INDNIC cocrystals.
245In case of INDNIC cocrystals with HP-β-CD, in turn, a
246signiﬁcant reduction in the diffraction patterns of both the
247physical and co-ground mixtures of INDNIC/HP-β-CD has
248been observed (Fig. 2, traces C, D). On the other hand, the
249co-evaporate mixture of INDNIC and HP-β-CD showed
250new very small peaks at (2θ) values of 8.44°, 11.80°,
25114.44°, 25.36° and 28.36° as compared to their physical
252and co-ground mixtures (Fig. 2, trace E). The disappear-
253ance of the crystalline peaks of INDNIC and recording of
254other new peaks could indicate the formation of structure
255with very low crystallinity [20]. On other words, co-
256evaporate system with HP-β-CD could have the potential to
257form an inclusion complex with INDNIC ﬁtted inside the
258HP-β-CD cavity and such complex appeared to be partially
259amorphous.
260The inclusion complexes of INDNIC with either β-CD
261or HP-β-CD were polycrystalline and of low crystallinity,
262respectively. Interestingly, Jambhekar et al. [21] concluded
263that, the inclusion complexes of IND itself with either β-
264CD or HP-β-CD were polycrystalline and amorphous,
265respectively.
266DSC study
267The DSC thermograms of INDNIC cocrystals, β-CD and
268their physical mixtures, co-ground and co-evaporate solid
269systems were presented in Fig. 3. Similarly, those with HP-
270β-CD were presented in Fig. 4.
271The peaks corresponding to the evaporation of water
272vapors from both β-CD and HP-β-CD appeared at 85 and
27360 °C; respectively (Figs. 3, 4; trace B) [22, 23].
274The physical and co-ground mixtures of INDNIC with
275β-CD showed a reduced intensity endothermic peaks at
276127.73 and 127.21 °C; respectively (Fig. 3; traces C and D)
277compared to that at 128.50 °C for INDNIC (Fig. 3; trace
278A). The presence of such endothermic peak in both the
279physical and co-ground mixtures still reﬂect the presence
280of free INDNIC in the prepared solid systems. Also, it was
Fig. 1 The PXRD patterns of a INDNIC, b β-CD, c physical mixture,
(D) co-ground mixture and (E) co-evaporate product. C, D and E are
with β-CD
Fig. 2 The PXRD patterns of a INDNIC, b HP-β-CD, c physical
mixture, (D) co-ground mixture and (E) co-evaporate product. C, D
and E are with HP-β-CD
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281 noted that the water evaporation endothermic peak was
282 shifted from 80 to 60 °C in case of the physical mixture
283 with β-CD (Fig. 3, trace C).
284 Similarly, it was found that the melting endotherm of
285 INDNIC physical and co-ground mixtures with HP-β-CD
286 appeared broader and shifted from 128.50 to 127.50 and
287 120.26 °C; respectively (Fig. 4, traces C and D). Further,
288 the broadening and reduction of that peak could be attrib-
289 uted to the incomplete complex formation via simple
290 physical and co-ground methods.
291 However, in case of co-evaporate mixtures with β-CD, a
292 small, highly broad endothermic peak was observed at
293 135.74 °C concomitantly with broadening of the water
294 evaporation peak (Fig. 3; trace E). This may indicate that
295 some sort of inclusion into the β-CD cavity was occurred
296 and there was still some INDNIC cocrystals cannot ﬁt
297 completely inside the β-CD cavity which is responsible for
298 this small endothermic broad peak [24].
299 On the other hand, the melting endotherm of co-evap-
300 orate with HP-β-CD was completely disappeared which
301 indicated that the new solid compound formed has an
302 amorphous structure (Fig. 4; trace E). These ﬁndings come
303 in accordance with the above mentioned PXRD results.
304 Moreover, the complete disappearance of the water
305evaporation peak of HP-β-CD in case of co-evaporate
306mixture with INDNIC could indicate that the cocrystal has
307penetrated into the HP-β-CD cavity and replaced the water
308molecules.
309Solid-state FTIR spectroscopic investigation
310FTIR spectroscopy was used to assess the interaction
311between the cocrystal and the two studied cyclodextrins in
312the solid state. The chemical interaction between the host
313and the guest molecules often leads to identiﬁable changes
314in the FTIR spectra of complexes. However, some of the
315changes are very subtle requiring careful interpretation of
316the spectra.
317The FTIR spectra of INDNIC, β-CD, HP-β-CD and their
318respective physical and cog-round mixtures and co-evap-
319orate products exhibited a number of differences in both
320the ﬁngerprint and high wavenumber regions (Figs. 5, 6).
321The υ (OH) regions in the FTIR spectra appear as very
322broad bands in the range of 3400–2500 cm−1 which are
323superimposed on the υ (CH) regions. Both the broad nature
324and the position of these FTIR bands are characteristic of
325hydrogen-bonded OH groups [25]. The differences in the
326shapes of these bands suggest that there may be associated
327variations in hydrogen bonding.
328By close inspection of the FTIR spectra of INDNIC, β-
329CD and their physical and ground mixtures and their co-
330evaporate products in the wavenumber range (3400–
3312500 cm−1), it could be noted that the characteristic sharp υ
332(OH) bands at 3413 and 3318 cm−1 and υ (NH2) bands at
3333285 and 3218 cm−1 of INDNIC were recorded as broader
334bands in the FTIR spectra of their physical and ground
335mixtures with reduced intensities but not in the spectrum of
336their co-evaporate products except the υ (OH) band at
3373413 cm−1 (Fig. 5a). That may indicate incomplete inclu-
338sion of the cocrystal in the β-CD cavity by physical mixing
339and co-grinding approaches. The same also may apply to
340the co-evaporation approach as indicated by the recording
341of the above weak υ (OH) band at 3413 cm−1 in the FTIR
342spectrum of the co-evaporate product (Fig. 5a, trace E).
343Based on the above observations, partial inclusion is more
344efﬁcient by the co-evaporation approach as compared to
345the two other methods which supports the previous ﬁndings
346from the PXRD and DSC data.
347In case of HP-β-CD only the sharp υ (OH) and υ (NH2)
348bands at 3413 and 3218 cm−1, respectively were recorded
349as broader bands in the FTIR spectra of their physical and
350ground mixtures with reduced intensities but not in the
351spectrum of their co-evaporate products (Fig. 6a). That
352may indicate more efﬁcient partial inclusion of the
353cocrystal in the HP-β-CD cavity by physical mixing and
354co-grinding approaches. However, in case of the co-
Fig. 3 The DSC thermograms of A INDNIC, B β-CD, C physical
mixture, D co-ground mixture and E co-evaporate product. C–E are
with β-CD
Fig. 4 The DSC thermograms of A INDNIC, B HP-β-CD, C physical
mixture, D co-ground mixture and E co-evaporate product. C–E are
with HP-β-CD
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355 evaporation approach, the inclusion complexation appears
356 to be complete (cf. that with β-CD).
357 By careful inspection of the FTIR spectra of INDNIC, β-
358 CD, and their physical and ground mixtures and their co-
359 evaporate products in the wavenumber range (1550–
360 1750 cm−1) region, in turn, rather interesting ﬁndings were
361 apparent (Fig. 5b).The characteristic υ(C=O) bands of
362 INDNIC at 1661 and 1680 cm−1 were recorded in the FTIR
363 spectra of their physical and ground mixtures. However in
364 the FTIR spectrum of their co-evaporate product they were
365 shifted to 1680 and 1691 cm−1, respectively with the
366 recording of a new υ(C=O) band at 1735 cm−1. These
367 signiﬁcant shifts together with the recording of a new
368 υ(C=O) band suggest the formation of new hydrogen
369 bonding between the cocrystal and the OH groups in the
370 interior cavity of β-CD during their more efﬁcient partial
371inclusion. The same was also noted with HP-β-CD
372(Fig. 6b). These shifts together with the recording of a new
373υ(C=O) band at 1735 cm−1 further conﬁrm the complete
374inclusion of the cocrystal with the HP-β-CD using the co-
375evaporation approach. These ﬁndings further conﬁrm the
376above PXRD and DSC observations.
377SEM analysis
378The SEM images of INDNIC, HP-β-CD and their co-
379evaporate and co-ground products, β-CD and its co-evap-
380orate product with INDNIC were presented in Fig. 7 (traces
381A, B, C D, E and F, respectively).
382Striking differences in the morphology of the particles
383were observed upon careful inspection of the SEM images.
384INDNIC particles were appeared as rectangular crystals
Fig. 5 a The FTIR spectra in
the wavenumber range (2500–
4000 cm−1) of A INDNIC, B β-
CD, C physical mixture, D co-
ground mixture and E co-
evaporate product. C–E are with
β-CD. b The FTIR spectra in the
wavenumber range (1550–
1750 cm−1) of A INDNIC, B β-
CD, C physical mixture, D co-
ground mixture and E co-
evaporate product. C–E are with
β-CD
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385 while HP-β-CD was presented as aggregated spherical
386 particles (Fig. 7, traces A and B). By comparing the mor-
387 phology of the co-evaporate and co-ground products of
388 INDNIC with HP-β-CD, it could be noted that, the co-
389 evaporate product appears as large irregular aggregates of
390 thick lumps which differ in morphology than both INDNIC
391 and HP-β-CD (Fig. 7, trace C), which could indicate the
392 loss of the crystalline shape of INDNIC and formation of
393 another complex structure with a new morphology. The co-
394 ground product, in turn, shows the loss of the spherical
395 appearance of HP-β-CD particles with the appearance of
396 the cocrystals (Fig. 7, trace D). The loss of the spherical
397 characters could be possibly attributed to the grinding
398 process. These observations are in agreement with our
399above ﬁndings from PXRD, DSC and FTIR studies which
400further conﬁrm the complete inclusion of the cocrystal with
401the HP-β-CD using the co-evaporation approach.
402To further conﬁrm our ﬁndings, the morphology of β-
403CD particles and their co-evaporate product with INDNIC
404were also compared. Interestingly, the cocrystals were
405appeared as a huge network of aggregated ﬁlaments on the
406surface of β-CD particles (Fig. 7, trace E). Such mor-
407phology may indicate the incomplete inclusion of the
408cocrystals using the co-evaporation approach.
409The variations in the particles morphology among the
410above products despite similar processing conditions could
411be explained by considerable differences in the crystal-
412lization kinetics or crystal lattices.
Fig. 6 a The FTIR spectra in
the wavenumber range (2500–
4000 cm−1) of A INDNIC,
B HP-β-CD, C physical mixture,
D ground mixture and E co-
evaporate product. C–E are with
HP-β-CD. b The FTIR spectra
in the wavenumber range
(1550–1750 cm−1) of
A INDNIC, B HP-β-CD,
C physical mixture, D ground
mixture and E co-evaporate
product. C–E are with HP-β-CD
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413In vitro dissolution study
414Figure 8 shows the dissolution proﬁles of IND, INDNIC
415and co-evaporate mixtures of INDNIC with β-CD and HP-
416β-CD in pH 6.8. It was found that the percentages of IND
417powder dissolved after 15 and 120 min were 19.32 % ± 6.5
418and 62.55 % ± 4.9; respectively. INDNIC cocrystals and
419co-evaporate mixtures of INDNIC with β-CD and HP-β-
420CD showed a signiﬁcantly (p \ 0.05; ANOVA/Tukey)
421higher increase in the dissolution rate of IND
42261.20 % ± 4.5, 62.96 % ± 1.8 and 75.16 % ± 2.7 after
42315 min; respectively compared with untreated IND powder,
42419.32 % ± 6.5, after the same time interval. Further, the
425co-evaporate mixture of INDNIC with HP-β-CD gives a
426signiﬁcantly (p\0.05; ANOVA/Tukey) higher increase in
Fig. 7 The SEM images of
a INDNIC, b HP-β-CD, c co-
evaporate product of INDNIC
with HP-β-CD, d co-ground
product of INDNIC with HP-β-
CD, e β-CD and f co-evaporate
product of INDNIC with β-CD
Fig. 8 The dissolution proﬁles of IND, INDNIC and the co-evaporate
mixtures of INDNIC with β-CD and HP-β-CD
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427 the dissolution rate of IND 75.16 % ± 2.7 and
428 86.76 % ± 0.7 after 15 and 120 min; respectively com-
429 pared to INDNIC cocrystals which showed 61.20 % ± 4.5
430 and 65.77 % ± 2.8 IND percentage released after the same
431 time. INDNIC cocrystals signiﬁcantly increased the dis-
432 solution rate of IND compared with the untreated IND
433 powder possibly as previously reported with indomethacin-
434 saccharin cocrystals [18]. Furthermore, the effect of HP-β-
435 CD on the dissolution rate of certain drugs was higher than
436 that of β-CD due to its higher water solubility and the
437 bigger capacity of its cavity [19, 26, 27]. It is worth to note
438 that, the co-evaporate mixture with HP-β-CD produces a
439 signiﬁcant (p \ 0.05; ANOVA/Tukey) rapid dissolution
440 after 15 and 120 min as compared to that with β-CD co-
441 evaporate system. That may be attributed to local solubil-
442 isation action operating in the micro-environment or the
443 hydrodynamic layer surrounding the cocrystals particles in
444 the early stages of the dissolution process. Additionally,
445 HP-β-CD dissolves in a short time compared with β-CD
446 thus improves the wettability of the cocrystals and hence
447 their dissolution [23]. Also, one could not neglect that, the
448 formation of the complete inclusion complex with a new
449 partially amorphous structure which could enhance the
450 dissolution process compared to the co-evaporate system
451 with β-CD and this is in agreement with PXRD, DSC and
452 FTIR studies.
453 Conclusions
454 Partial and complete inclusion complexes of INDNIC
455 cocrystals with β-CD and HP-β-CD were prepared suc-
456 cessfully by the co-evaporation method in a molar ratio of
457 1:1 of the guest to host molecules. This was conﬁrmed by
458 various analytical techniques. The co-evaporate mixture of
459 INDNIC with HP-β-CD showed new morphological
460 structure as observed from SEM Study. The prepared
461 inclusion complexes enhanced the dissolution rate of IND
462 signiﬁcantly as compared with the untreated IND and
463 INDNIC cocrystals. Furthermore, the highest improvement
464 in IND in vitro dissolution was observed in the inclusion
465 complex prepared with HP-β-CD.
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